MedTrace Logo

Severe Primary Hand Hyperhidrosis Treatment With Topical Administration of Victorhy

NCT06645509 · Status: TERMINATED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 58

Last updated 2025-06-22

No results posted yet for this study

Summary

The objective of this study is to assess the efficacy and safety of Victorhy, a topical TTB gel in patients with severe primary hand hyperhidrosis.

Conditions

  • Palmar Hyperhidrosis

Interventions

DRUG

TTB gel (dose 1)

A topical administration of Victorhy (TTB gel) to both hands, once daily for 28 days

DRUG

TTB gel (dose 2)

A topical administration of Victorhy (TTB gel) to both hands, once daily for 28 days

DRUG

Placebo

A topical administration of a vehicle (Placebo) gel to both hands, once daily for 28 days

Sponsors & Collaborators

  • Dryox Health

    lead INDUSTRY

Principal Investigators

  • Clara Matas Nada, MD · Hospital Santa Caterina de Salt

  • José Gregorio Álvarez Fernández, MD · Hospital Pardo de Aravaca (Hospital Universitario Vithas Madrid Aravaca)

  • Carmen Rodríguez Cerdeira, MD · Hospital Vithas Nosa Señora de Fátima (Hospital Vithas Vigo)

  • Enrique Herrera Acosta, MD · Hospital Vithas Parque San Antonio (Hospital Vithas Málaga)

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-04-29
Primary Completion
2025-06-02
Completion
2025-06-02

Countries

  • Spain

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06645509 on ClinicalTrials.gov